PRDS NASDAQ
Pardes Biosciences, Inc.
1W: +0.0%
1M: +3.4%
3M: +14.3%
1Y: -31.9%
$2.18
Last traded 2023-09-08 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$100M
-359.3% ▼
Net Income
-$93M
-142.4% ▼
EPS (Diluted)
$-1.61
-136.8% ▼
EBITDA
-$93M
-342.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 |
|---|---|---|
| Revenue | $0 | $0 |
| YoY Growth | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Gross Margin | — | — |
| R&D Expenses | $28M | $70M |
| SG&A Expenses | $10M | $29M |
| Operating Expenses | $38M | $100M |
| Operating Income | $38M | -$100M |
| Operating Margin | — | — |
| Interest Expense | $30K | $3M |
| Income Before Tax | $0 | -$97M |
| Tax Expense | $30K | -$3M |
| Net Income | -$39M | -$93M |
| Net Margin | — | — |
| EPS (Diluted) | $-0.68 | $-1.61 |
| EBITDA | $39M | -$93M |
| Shares Outstanding | 57M | 58M |